Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - New York Stock Exchange, Inc. - BE0003816338 - Common Stock - Currency: USD

9.05  -0.05 (-0.55%)

Fundamental Rating

4

Overall CMBT gets a fundamental rating of 4 out of 10. We evaluated CMBT against 210 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT scores excellent on profitability, but there are concerns on its financial health. CMBT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT's Return On Assets of 37.43% is amongst the best of the industry. CMBT outperforms 96.19% of its industry peers.
CMBT's Return On Equity of 122.80% is amongst the best of the industry. CMBT outperforms 96.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.29%, CMBT is in the better half of the industry, outperforming 79.05% of the companies in the same industry.
Industry RankSector Rank
ROA 37.43%
ROE 122.8%
ROIC 12.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

CMBT's Profit Margin of 104.40% is amongst the best of the industry. CMBT outperforms 99.52% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT has a Operating Margin of 39.03%. This is amongst the best in the industry. CMBT outperforms 80.95% of its industry peers.
CMBT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 60.19%, CMBT is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CMBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for CMBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 1.51. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT has a Altman-Z score of 1.51. This is comparable to the rest of the industry: CMBT outperforms 54.76% of its industry peers.
A Debt/Equity ratio of 1.94 is on the high side and indicates that CMBT has dependencies on debt financing.
The Debt to Equity ratio of CMBT (1.94) is worse than 82.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACC1.26
WACC9.78%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.78 indicates that CMBT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.78, CMBT is doing worse than 71.43% of the companies in the same industry.
CMBT has a Quick Ratio of 0.78. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CMBT (0.71) is worse than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.71
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

4

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.11%.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.49% on average per year.
The Revenue for CMBT has decreased by -24.33% in the past year. This is quite bad
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-13.11%
EPS 3YN/A
EPS 5Y43.49%
EPS Q2Q%-94.09%
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-66.48%

3.2 Future

The Earnings Per Share is expected to decrease by -28.11% on average over the next years. This is quite bad
CMBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.64% yearly.
EPS Next Y-61.51%
EPS Next 2Y-28.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.02%
Revenue Next 2Y15.61%
Revenue Next 3Y9.64%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.44, the valuation of CMBT can be described as very cheap.
Based on the Price/Earnings ratio, CMBT is valued cheaper than 99.05% of the companies in the same industry.
When comparing the Price/Earnings ratio of CMBT to the average of the S&P500 Index (29.35), we can say CMBT is valued rather cheaply.
The Price/Forward Earnings ratio is 6.34, which indicates a rather cheap valuation of CMBT.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaply inside the industry as 80.48% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CMBT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.44
Fwd PE 6.34
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.41
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -28.11% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y-28.11%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

CMBT has a Yearly Dividend Yield of 63.20%, which is a nice return.
CMBT's Dividend Yield is rather good when compared to the industry average which is at 7.06. CMBT pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, CMBT pays a better dividend.
Industry RankSector Rank
Dividend Yield 63.2%

5.2 History

On average, the dividend of CMBT grows each year by 91.85%, which is quite nice.
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)91.85%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

CMBT pays out 76.95% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CMBT has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP76.95%
EPS Next 2Y-28.11%
EPS Next 3YN/A
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (3/7/2025, 8:15:17 PM)

9.05

-0.05 (-0.55%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-06 2025-05-06/bmo
Inst Owners1.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.99B
Analysts80
Price Target13.48 (48.95%)
Short Float %1.85%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield 63.2%
Yearly Dividend3.12
Dividend Growth(5Y)91.85%
DP76.95%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.35%
Min EPS beat(2)-45.02%
Max EPS beat(2)-3.67%
EPS beat(4)2
Avg EPS beat(4)130.92%
Min EPS beat(4)-45.02%
Max EPS beat(4)330.29%
EPS beat(8)6
Avg EPS beat(8)108.55%
EPS beat(12)9
Avg EPS beat(12)84.06%
EPS beat(16)11
Avg EPS beat(16)63.94%
Revenue beat(2)1
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-10.8%
Max Revenue beat(2)6.27%
Revenue beat(4)2
Avg Revenue beat(4)2.21%
Min Revenue beat(4)-10.8%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.36%
Revenue beat(12)10
Avg Revenue beat(12)37.77%
Revenue beat(16)14
Avg Revenue beat(16)43.7%
PT rev (1m)-15.94%
PT rev (3m)-20.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.98%
EPS NY rev (3m)-9.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-10.03%
Revenue NY rev (3m)-11.06%
Valuation
Industry RankSector Rank
PE 2.44
Fwd PE 6.34
P/S 1.42
P/FCF N/A
P/OCF 4.34
P/B 1.67
P/tB 1.69
EV/EBITDA 6.41
EPS(TTM)3.71
EY40.99%
EPS(NY)1.43
Fwd EY15.78%
FCF(TTM)-3.01
FCFYN/A
OCF(TTM)2.09
OCFY23.05%
SpS6.37
BVpS5.42
TBVpS5.35
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 37.43%
ROE 122.8%
ROCE 15.56%
ROIC 12.29%
ROICexc 12.43%
ROICexgc 12.49%
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Debt/EBITDA 3.25
Cap/Depr 675.47%
Cap/Sales 79.96%
Interest Coverage 5.02
Cash Conversion 64.34%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.71
Altman-Z 1.51
F-Score4
WACC9.78%
ROIC/WACC1.26
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.11%
EPS 3YN/A
EPS 5Y43.49%
EPS Q2Q%-94.09%
EPS Next Y-61.51%
EPS Next 2Y-28.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-66.48%
Revenue Next Year9.02%
Revenue Next 2Y15.61%
Revenue Next 3Y9.64%
Revenue Next 5YN/A
EBIT growth 1Y-39.07%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year77.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-232.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.18%
OCF growth 3YN/A
OCF growth 5Y11.04%